News round up 8 January 2018

NEC and TAU to welcome startups to class
NEC and Tel Aviv University have established an incubator called AlphaC in order to support cyber technology developers.

NexImmune orchestrates $23m series A
Johns Hopkins University spinout NexImmune has raised series A funding a year after being acquired by a consortium of individual investors in January 2017.

Purdue eight score $160,000
Purdue University-linked companies operating the in renewable energy, sustainable transport and oncology sectors are among those to have secured $20,000 in initial funding.

CWRU spots Alevca Ocular’s potential
Alevca Ocular will seek series A investors for initial research on eye inflammations resulting from surgical procedures.

Rewind records $18.3m series A
The KU Leuven spinout is researching remedies for debilitating diseases of the nervous system such as multiple sclerosis.

Bluefield Innovations screens first project
An oncology team led by Johns Hopkins professor Marikki Laiho has been backed by the commercialisation fund, becoming its first recipient.

Intel joins Swarm64 for series B round
Springfondet-backed data analytics software producer Swarm64 has raised $12.5m in a round that was co-led by Intel Capital, taking its total funding to more than $21m.

Deal net: 22 December 2017 – 5 January 2018
The Global University Venturing deal net rounds up all the latest smaller deals and tracks emerging companies accessing university funds.